Physician profile
Bryan Tan
NPI 1366937211
$5,023.13
in general payments reported to CMS, 2019-2025
13 companies · $1,962 in 2025
The $1,962 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.98 · 2023: $423 · 2024: $2,614 · 2025: $1,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,680 · Travel and Lodging: $1,812 · Education: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,679.61 |
| Travel and Lodging | $1,812.09 |
| Education | $507.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,782.94 | 2023-2025 | Gallant, Proclaim, Cardiomems |
| Amgen INC. | $275.66 | 2024-2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $246.06 | 2025 | Attruby |
| Abiomed | $244.63 | 2025 | |
| Medtronic, INC. | $139.06 | 2024 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $101.02 | 2023 | Camzyos |
| Cardiva Medical, INC. | $99.89 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Medical Device Business Services, INC. | $42.75 | 2025 | Vistaseal |
| Pfizer INC. | $26.14 | 2021-2025 | |
| Boston Scientific Corporation | $21.91 | 2025 | Accolade Sr |
| Ethicon US, LLC | $17.41 | 2025 | Stratafix, Surgicel Nu-Knit, Vistaseal |
| Cmp Pharma, INC. | $14.15 | 2023 | Norliqva |
| Janssen Pharmaceuticals, INC | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.